NLRP3/IL-1 and MyD-88/CCL2 pathway were reduced by inclisiran under exposure to anthracyclines and HER-2 blocking agent

Back

ESC2025 Premium Access

NLRP3/IL-1 and MyD-88/CCL2 pathway were reduced by inclisiran under exposure to anthracyclines and HER-2 blocking agent

Session: The role of prevention in cardio-oncology

Topic: Cardio-Oncology

Speaker: Doctor V. Quagliariello (Naples, IT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Vincenzo Quagliariello

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)

0 follower

8 more presentations in this session

Predicting late cardiovascular events in allogeneic hematopoietic stem cell transplant recipients

Speaker: Doctor T. Goncalves (Paris, FR)

Speckle-tracking echocardiography in chemotherapy-induced cardiotoxicity: a predictor or monitoring tool?

Speaker: Doctor N. Espinola-Zavaleta (Mexico City, MX)

Quality of care and long-term survival after ST-elevation myocardial infarction in adults with cancer: a nationwide cohort study

Speaker: Doctor M. Dafaalla (Keele, GB)

Sex differences in cardiovascular complications after allogeneic hematopoietic stem cell transplantation

Speaker: Doctor T. Goncalves (Paris, FR)

Natriuretic peptides may be suitable for screening long-term heart failure risk in breast cancer survivors after cardiotoxic chemotherapy

Speaker: Doctor J. Wong (Melbourne, AU) Professor T. Marwick (Melbourne, AU)

Access the full session

The role of prevention in cardio-oncology

Speakers: Doctor V. Quagliariello, Doctor T. Goncalves, Doctor N. Espinola-Zavaleta, Doctor M. Dafaalla, Doctor T. Goncalves...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources